<p>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</p> - Concepedia

Concepedia

Publication | Open Access

<p>Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States</p>

DOI Full Paper Access

99

Citations

25

References

2020

Year

Tracey Weiss, Richard D. Carr, Sampriti Pal, Lingfeng Yang, Baanie Sawhney, Robert Boggs, Swapnil Rajpathak, Kristy Iglay

Patient Preference and Adherence

Abstract

Over half of T2DM patients initiating GLP-1 RA were non-adherent and the majority (70.1%) discontinued therapy by 24 months. Reasons for non-adherence and discontinuation merit further research.

References

	Year	Citations

Page 1